Orchard was founded in 2015 through a partnership between UCL Business (UCLB), the commercialisation company for UCL, and F-Prime Capital Partners. Its revolutionary treatments are the result of decades long gene therapy research and clinical work led by UCL Professors Bobby Gaspar and Adrian Thrasher, both based at UCL Great Ormond Street Institute of Child Health.
Golden managing partner Matt Golden said it was a ‘clean deal’ free of complex structured terms that financiers have increasingly demanded from startups to guarantee them a larger share of proceeds when they sell